One of the traits most consistently seen in females with Turner syndrome is premature ovarian insufficiency (POI). The biological mechanisms underlying the germ cell atresia that leads to infertility in most women with Turner syndrome are unclear. Given that telomeres are important for proper chromosomal pairing and other early steps in meiosis and oogenesis, one can conjecture that perturbations in telomere length and/or function might contribute to the POI associated with Turner syndrome. Also, one can speculate that epigenetic modifications that arise in response to asynapsis, as well as the resetting of the epigenome during embryogenesis, could contribute to monosomy X-related germ cell atresia. Moreover, errors in recombination-based DNA repair might contribute to the failure of cells lacking all, or a portion of, a second sex chromosome to successfully complete oogenesis. This article presents a review of the extant literature related to telomere length and/or epigenetic patterns associated with POI in females with a monosomy X complement (in humans and animal models). A goal of this review is to inspire researchers to use new technological advances to better characterize the components of the biological cascade leading to early germ cell loss in females with Turner syndrome.
| INTRODUCTION
Turner syndrome is the only viable monosomy condition in humans (Hook & Hamerton, 1977) . While this sex chromosomal condition is often associated with a monosomy X karyotype, the chromosomal complements of females with Turner syndrome show significant heterogeneity, with both numerical and structural sex chromosomal findings, as well as mosaicism for these findings, being observed in this cohort (Hook & Warburton, 1983 , 2014 . Not surprisingly, due to this cytogenetic heterogeneity, females with Turner syndrome also show phenotypic variability in the presence and/or severity of the more than 60 traits that have been associated with this condition (Gravholt et al., 2017) . One of the most frequently noted phenotypic outcomes noted in females with Turner syndrome is premature ovarian insufficiency (POI), which often leads to infertility. In 1966, Singh and Carr (1966) observed that first trimester fetuses with a monosomy X chromosomal complement showed the presence of primordial germ cells, with no clear histological differences being apparent between the fetuses with a 45,X compared to a 46,XX chromosomal complements up to the third month of gestational age, but in later gestational age specimens, fetuses with monosomy X showed increases in gonadal connective tissue. Building on this observation, Modi, Sane, and Bhartiya (2003) observed that at 15 weeks gestational age, the ovaries from fetuses with a 45,X chromosomal complement had very few cells that were apoptotic (as assessed using a terminal deoxynucleotidyl transferase dUTP nick end labeling [TUNEL] assay), while ovaries from later gestational age fetuses with a 45,X karyotype showed apoptotic patterns in the vast majority of cells. Although the sample sizes in these hallmark studies were small, these investigators, along with Reynaud et al. (2004) , recognized that fetuses with a 45,X complement showed a clear progression from germ cells being present in early gestation, to showing significantly increased apoptotic indices by 15-weeks gestational age, to being devoid/nearly devoid of germ cells by 22 weeks gestational age. Thus, the results of these studies supported the conclusion that the infertility associated with Turner syndrome results from premature apoptosis of germ cells rather than a lack or void of the initial formation of germ cells. While multiple biological factors have been conjectured to contribute to the POI associated with Turner syndrome, as well as POI seen in women with a typical sex chromosomal complement (46,XX), the biological mechanisms underlying germ cell attrition in fetuses with a monosomy/partial monosomy X complement remain largely unknown. In their provocative hypothesis developed to explain POI and reproductive aging in women with a 46,XX chromosomal complement, Keefe, Marquard, and Liu (2006) conjectured that telomere attrition may be a potential factor contributing to germ cell attrition and female reproductive senescence. The primary aim of this report is to review biological factors that are thought to contribute to POI in females with Turner syndrome and to assess the potential feasibility that telomere length, as well as aberrant epigenetic modification patterns, might contribute to the biological cascade leading to POI in females who have a chromosomal complement associated with Turner syndrome (females who lack all, or a portion of, a second sex chromosome [with or without mosaicism]).
| HAPLOINSUFFICIENCY OF GENES LOCALIZED TO THE X CHROMOSOME
One approach used to better understand the POI associated with Turner syndrome has been to evaluate both the fertility status and karyotypic findings present in women with Turner syndrome to determine if a consistent karyotype: phenotype correlation emerged (Figure 1 ). While much heterogeneity has been noted, with clear overlap in patterns being present, this approach has enabled investigators to identify potential candidate genes on the X chromosome that could be "key" contributors to the POI biological cascade (Cordts, Christofolini, Dos Santos, Bianco, & Barbosa, 2011; Persani, Rossetti, Cacciatore, & Bonomi, 2009; Simpson & Rajkovic, 1999; Zinn & Ross, 2001 ). These genes include (but are not limited to), ZFX, UBA1, USP9X, BMP15, POF2, DACH2, DIAPH2, POF1, FMR1, and FMR2. Of particular interest is the Bone Morphogenetic Protein-15 (BMP15) gene, which is thought to function in oocyte maturation and follicular development. Mutations in this gene have been observed in a subset of females with idiopathic POI, but the presence and/or proportion of women with POI who show BMP15 mutations has varied between studies, with its role in the attainment/retention of oocytes in humans remaining controversial (Chand, Ponnampalam, Harris, Winship, & Shelling, 2006; Di Pasquale, Beck-Peccoz, & Persani, 2004; Di Pasquale et al., 2006; Dixit et al., 2006; Laissue et al., 2006; Ledig, Röpke, Haeusler, Hinney, & Wieacker, 2008; Takebayashi et al., 2000; Zhang, Shi, Wang, & Chen, 2007) . In contrast, the BMP15 gene has been clearly associated with premature ovarian failure in sheep, thereby providing support for the potential importance of haploinsufficiency of this gene in the failure to attain successful fertility in at least one non-human model system (Bodin et al., 2007; Braw-Tal et al., 1993; Davis, McEwan (Conway, Payne, Webb, Murray, & Jacobs, 1998) , with the risk appearing to have a nonlinear relationship based on the size of the CGG repeat the woman carries Bretherick, Fluker, & Robinson, 2005; Sullivan et al., 2005) . The biological mechanism(s) whereby a permutation of the FMR1 predisposes/leads to POI is/are not fully known, but may include accelerations in the rate of fetal germ cell atresia (Allen et al., 2007) . While deletions of the FMR2 gene have been associated with POI (Espeche et al., 2017; Murray, Webb, Dennis, Conway, & Morton, 1999) , this relationship has not been as clearly established as that of FMR1 (Cordts et al., 2011) .
| TELOMERE LENGTH IN REPRODUCTIVE AGING AND PREMATURE OVARIAN INSUFFICIENCY
Keefe and his research team have hypothesized that in women with two structurally normal X chromosomes (46,XX) telomere shortening is a "primary driver" of reproductive aging (Kalmbach et al., 2013; Keefe et al., 2006) . Based on their novel hypothesis, one could conjecture that telomere length might also contribute to the POI observed FIGURE 1 Potential X chromosomal candidate loci contributing to the infertility associated with Turner syndrome. Genes present on the X chromosome that have been identified as potential candidates contributing to POI include those localized to regions that escape inactivation, as well as genes localized to other areas of the X chromosome. The genes that have shown the strongest association with POI are highlighted in bold font (BMP15 and FMR1) in females with Turner syndrome. Telomeres are specialized structures found at the ends of chromosomes that maintain chromosomal integrity by preventing end-to-end fusion. In humans, the telomere forms a T-loop structure that is comprised of the telomere DNA repeat sequences (TTAGGG) n , along with associated proteins. Thus, perturbations in the integrity of either the DNA sequence or the protein structure (also referred to as the shelterin complex or telomere "cap") could lead to alterations in cellular function. In somatic cells, telomere attrition has been noted to arise following mitotic cell divisions (particularly in cells with minimal/absent expression of telomerase), as well as exposure to reactive oxygen species (Reichert & Stier, 2017) . Indeed, the repeat sequences that are localized to the telomere have been shown to be particularly sensitive sites ("hot spots") for reactive oxygen species degradation (Oikawa & Kawanishi, 1999; Smith, 2018; von Zglinicki, 2002) . Once a telomere becomes critically short, it triggers a senescence pathway, which can then lead to apoptosis (directly or via gene network interactions). Telomere attrition has been associated with aging, as well as numerous health and behavioral conditions, including (but not limited to) cancer, stress exposure (both social as well as biological), dementia, heart disease and cardiomyopathies, diabetes, depression, childhood adversity, exposure to chemotherapy, and even all-cause mortality (Blackburn, Epel, & Lin, 2015; Chang et al., 2018; Starkweather et al., 2014) . (Table 1) . However, differences in the methods used, assessment of somatic (vs. germline) cells, as well differences in the participant inclusion criteria across studies, have complicated the interpretation of a potential association between telomere length and reproductive aging in humans. In contrast, studies using female mice, which allows one to avoid some of the challenges encountered in studies of humans, showed that telomere shortening (obtained via knockout of telomerase activity) in fourth generation mice resulted in germline cells containing increased rates of aberrant meiotic spindles, as well as anomalies in chromosomal congregation and segregation (Liu, Blasco, & Keefe, 2002) . Moreover, when compared to wild type mice, the female mice having these manipulated shortened telomeres showed impairments in meiotic chromosomal pairing and reduced levels of recombination, as well as early meiotic arrest (Liu et al., 2004) .
| DOES TELOMERE ATTRITION CONTRIBUTE TO A LACK OF MEIOTIC SYNAPSIS AND CHIASMATA FORMATION, THEREBY LEADING TO DISRUPTION OF MEIOSIS?
Telomeres are thought to be essential for facilitating homolog pairing in meiosis, as well as meiotic centrosome assembly, with this process (which occurs during leptotene to zygotene and prior to entry into pachytene), being visualized as a "bouquet" formation (Klutstein, Fennell, Fernández-Alvarez, & Cooper, 2015; Scherthan et al., 1996) .
The importance of this telomere "bouquet" formation in the progression of meiosis and pairing, is underscored by the observation of this phenomenon in both humans and non-humans (evolutionarily conserved), albeit with differences in the sites of synapsis initiation (and/or telomere involvement in pairing initiation) being noted between sexes and among mammals (Gruhn et al., 2016; Harper, Golubovskaya, & Cande, 2004; Scherthan, 2001 ). An early prerequisite step leading to the formation of the meiotic telomere bouquet involves tethering of the telomeres to the inner nuclear membrane.
This attachment is achieved via interactions between proteins localized to the telomeric "cap" (such as TRF, TERB1/2) and proteins localized to the inner nuclear membrane (MAJIN; Speedy A, Cdk2, SUN1/2; KASH5; Pendlebury et al., 2017; Shibuya et al., 2015; Tu et al., 2017; Yamamoto, 2014) . The congression of the telomeres to form the bouquet structure is then thought to be driven by the microtubule-organizing center at the telomere (also called the "telocentrosome") via microtubule motors (reviewed by Yamamoto, 2014) .
Thus, if a telomere is aberrantly short and/or lacks its typical telomeric cap, the cell may be compromised in its ability to progress through meiosis or for its homologous chromosomes to optimally initiate and/or complete the pairing process. Failure of proper homolog pairing may trigger checkpoints or other mechanisms that lead to meiotic cessation and result in germ cell atresia. Indeed, the absence of an obligatory sex chromosome paring event, due to absence of a second sex chromosome, has been conjectured to be a trigger for meiotic cessation in females with a monosomy X complement (Ogata & Matsuo, 1995) . Using a mouse model, Cloutier et al. (2015) showed that in 55% of the oocytes obtained from female mice with a monosomy X complement, their single X chromosome was asynapsed, with the remaining oocytes having their single X chromosome "self-synapsed."
They further noted that oocytes with an asynapsed X chromosome were eliminated during diplonema, and conjectured that this germ cell is associated with germ cell restoration is that its ablation leads to a "reversal" of the epigenetic silencing of key X chromosomal genes whose expression is essential for the development/retention of oocytes (such as Bmp15; Fmr1; Zfx; Cloutier et al., 2015) .
| ARE DNA REPAIR COMPROMISES A DRIVING FORCE CONTRIBUTING TO THE POI ASSOCIATED WITH TURNER SYNDROME?
In addition to telomere attrition, another biological factor that has been conjectured to contribute to reproductive aging in females with a typical chromosomal complement (46,XX) is compromised oocyte DNA repair (Johnson & Keefe, 2013; Titus, Stobezki, & Oktay, 2015) .
However, given that germ cell loss arises prior to birth (during early meiosis) in most females/embryos with a chromosomal complement associated with Turner syndrome, the role for compromises in the repair of DNA damage arising in response to environmental exposures seems unlikely to be an strong contributor to their POI. In contrast, DNA repair related to meiotic recombination could be a contributory factor to germ cell loss. Indeed, due to the telomere cap exchange that occurs in tethering the telomeres to the inner nuclear envelope in meiosis, the telomeres are exposed and placed into close proximity with one another, thereby increasing their risk for a telomeretelomere fusion event(s). One could speculate that the "resetting" or "reprogramming" leading to elongation of telomeres that has been observed in early embryogenesis in a subset of tissues of some organisms could serve to reduce chromosomal instability and/or aberrant DNA repair in meiosis. This "resetting" phase has also been suggested to be an important step for acquiring pluripotency in embryonic stem cells (Liu, 2017; Liu et al., 2007) . Using a mouse model system, Wang et al. (2018) could lead to oocyte senescence and/or apoptosis (Titus et al., 2015) .
| COULD CHROMOSOMAL COMPLEMENTS ASSOCIATED WITH TURNER SYNDROME LEAD TO ABERRANT EPIGENETIC PATTERN ESTABLISHMENT IN OOGENESIS?
Recent advances in reproductive biology have allowed for improvements in our knowledge of epigenetic changes that arise early in embryogenesis to "erase" and re-establish epigenetic patterns in the embryo (Hanna, Demond, & Kelsey, 2018; Leseva, Knowles, Messerschmidt, & Solter, 2015) . These modifications, which include changes to DNA methylation, as well as histones, noncoding RNAs, and potentially other modifications, can impact chromatin conformation and orchestrate gene expression cascades that vary in different tissues throughout embryogenesis. As noted above, Cloutier et al. (2015) provided strong evidence for a role for epigenetic marks (specifically phosphorylated H2afx) in the success, or failure, of oocytes to progress to the diplonema phase of meiosis. In mice, another epigenetic modification associated with the successful completion of oogenesis that has recently been identified involves histone 3 trimethylation of K4, mediated by the Mll2 gene (Hanna, Taudt, et al., 2018) . These researchers showed that decreases in the histone H3 trimethylation of K4, due to loss of the Mll2 gene, can lead to failure of the oocytes to mature or to ovulate.
Data emerging from studies of embryonic stem cells and induced pluripotent stem cells support a role for telomere length and the "re-setting" of telomere length, in the progression of chromatin remodeling that is necessary for the establishment of epigenetic modifications in germ cell maturation (Liu, 2017; Zeng, Liu, Sun, Lu, & Lin, 2017) . Interestingly, in somatic cells, differences in DNA methylation patterns have been observed in cells from females with Turner syndrome compared to those seen in females with 2 (or 3) structurally normal X chromosomes ( Alvarez-Nava & Lanes, 2018; Trolle et al., 2016) . Of the genes that showed differential methylation patterns, Trolle et al. (2016) identified the KDM6A (Lysine Demethylase 6A) gene as a possible candidate contributing to POI, as this gene has been suggested to play a role in the regulation of other genes that are important for germ cell development (Berletch, Deng, Nguyen, & Disteche, 2013) .
In addition to genome-wide epigenetic modifications, the epigenetic changes associated with the "erasure" or "reactivation" of the inactive X during oogenesis may provide another opportunity for epigenetic factors to contribute to the POI associated with Turner syndrome. The specific steps and/or processes leading to this reactivation have not yet been clearly defined in humans (or non-humans).
However, based on a "gene dosage" hypothesis, one could speculate that a disomic dosage for at least a subset of the genes that "escape"
inactivation (including those localized to the pseudoautosomal region), may be required to successfully initiate and/or progress through meiosis/oogenesis. Alternatively, one might conjecture that the initial X inactivation (or reactivation of the inactivated X) is a trigger that leads to other epigenetic changes that are important for the function of gene products (on the X chromosome or on autosomes) that are needed for the successful development and retention of germ cells.
Recent advances leading to the generation of human oogonia from induced pluripotent stem cells may provide a new tool for enhancing our understanding of the epigenetic and other biological changes that arise in germ cell development in females with typical sex chromosomes complements (46,XX), as well as chromosomal complements associated with Turner syndrome (Yamashiro et al., 2018) .
| CHALLENGES FOR IDENTIFYING BIOLOGICAL CHANGES RELATED TO PREMATURE OVARIAN INSUFFICIENCY IN FEMALES WITH TURNER SYNDROME
One of the largest hurdles for recognizing biological differences that ultimately lead to POI in females with Turner syndrome is a lack/limitation of access to their germline cells at the time when these biological : perturbations in the function of the genes involved in resetting telomere length in early embryogenesis; alterations in the proteins comprising the telomere cap such that the telomere is not optimally tethered to the inner nuclear membrane, thereby altering the formation of the telomere bouquet; increased susceptibility of the telomere to DNA damage and/or suboptimal repair of recombination-based DNA breaks; the presence of H2AFX on the single asynapsed X chromosome (leading to silencing of genes necessary for oogenesis progression); alterations in the epigenome, including changes involving H3K4me3 marks; and potential epigenetic alterations triggered by the lack of X-inactivation (due to only one X chromosome per autosomal set). In the few females with Turner syndrome who have germ cells that are retained after their birth, these gametes could undergo a more rapid atresia process due to DNA repair compromises, possibly related to telomere attrition, as well as other factors changes are occurring, as most of the alterations leading to germ cell atresia arise in utero during early embryogenesis. One approach that investigators have used to circumvent this challenge has been to evaluate somatic cells to assess biological patterns that might be comparable to those present in germ cells. Although telomere length has been extensively studied in males and females having typical chromosomal complements, we identified only one report of telomere length in females with Turner syndrome. In this study, Kveiborg, Gravholt, and Kassem (2001) did not detect a significant difference in the telomere lengths of peripheral blood leukocytes from 30 females with Turner syndrome compared to age-matched control females (using a telomere restriction fragment length assay). Given that telomere lengths have been noted to "re-set" during early embryogenesis, it is not clear if the lengths of telomeres in peripheral blood are good proxies for assessing the status of telomeres in early germ line cells. Indeed, evidence from mice suggests that telomere lengths in oocytes are shorter than those present in somatic cells (Liu et al., 2007) . These investigators also concluded that oocytes have the ability to alter telomere lengths, with this process arising via a recombination-based alternative mechanism (Liu et al., 2007) . Interestingly, in humans, telomere lengths in mature oocytes have been shown to be significantly shorter than those present in immature oocytes (Turner & Hartshorne, 2013) .
Much of the knowledge, we have gained regarding X-inactivation, meiosis, and early germ cell development has come from studies completed using animal models; primarily mice. However, clear differences in processes leading to X-inactivation, germ cell epigenetic modifications, and telomere length have been identified between mice and humans (Hanna, Demond, et al., 2018; Migeon, 2017) . For example, telomeres are 5-to 10-fold longer in mice (50-150 kb lengths) compared to humans (10-15 kb lengths) and show differences in the mechanisms used for telomere lengthening in meiosis (Calado & Dumitriu, 2013; Gomes, Shay, & Wright, 2010; Kosebent, Uysal, & Ozturk, 2018) . Importantly, while mice with monosomy X have fewer oocytes and have a shorter reproductive lifespan than mice with two X chromosomes, mice with monosomy X are fertile (Burgoyne & Baker, 1981 , 1985 Lyon & Hawker, 1973) . Thus, it seems advisable to use caution when inferring the applicability of POI-related mechanisms that are recognized from studies in animal models to the scenario arising in humans.
In addition to tissue and species differences, another factor to consider when comparing the results of telomere length assessments that are derived from different research teams is the methodology they used to quantify telomere length estimates (Lai, Wright, & Shay, 2018; Montpetit et al., 2014) . It is important to note that a single or small number of telomeres having a critically short length could go undetected in assays designed to detect mean telomere lengths (Lai et al., 2018; Montpetit et al., 2014) . If a single critically short telomere is the trigger for determining the onset of senescence or cell fate in oocytes, as it is in most somatic cells, then it is important that the assays used to quantify telomere lengths provide the potential to recognize each separate, chromosome-specific telomere (Lai et al., 2018 ).
An additional factor to consider when interpreting data related to the biological consequence(s) of a partial or full monosomy for chromosome X is the background genetic make-up of each individual.
Females with Turner syndrome show a rich level of variation in their chromosomal complements, with mosaicism being noted among several (or most) females with Turner syndrome (Hook & Warburton, 2014) . One study design that could be used to better tease apart the underlying biological differences leading to phenotypic consequence in females with Turner syndrome is to compare patterns that are present in the isogenic monosomic and disomic cells within an individual who has sex chromosome mosaicism. This approach would enable investigators to "unmask" the consistent effects of a monosomic (or partially monosomic) complement since extraneous differences due to background genetic factors could be removed (Papavassiliou, Charalsawadi, Rafferty, & Jackson-Cook, 2015) .
In summary, multiple factors are likely to contribute to the biological cascade of changes leading to POI in females with Turner syndrome ( Figure 2 ). The development of new in vitro gametogenesis technologies (Yamashiro et al., 2018) , coupled with the development/ enhancement of assays that enable investigators to assess epigenetic and telomeric changes using small numbers of cells (even single cells; Hanna, Taudt, et al., 2018; Lai et al., 2018) , provide investigators with expanded "tool kits" to utilize for future studies to identify the biological changes arising in the germ cells of embryos/fetuses with a monosomy X complement (or its variants). It is feasible that improvements in our knowledge of the processes leading to POI could open avenues for potential preservation of fertility options for women with Turner syndrome (Grynberg et al., 2016) . 
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